Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Return on Capital Employed (2018 - 2020)

Historic Return on Capital Employed for Cogent Biosciences (COGT) over the last 3 years, with Q4 2020 value amounting to 0.45%.

  • Cogent Biosciences' Return on Capital Employed rose 3500.0% to 0.45% in Q4 2020 from the same period last year, while for Dec 2020 it was 0.45%, marking a year-over-year increase of 3500.0%. This contributed to the annual value of 0.6% for FY2020, which is 100.0% down from last year.
  • Cogent Biosciences' Return on Capital Employed amounted to 0.45% in Q4 2020, which was up 3500.0% from 1.05% recorded in Q3 2020.
  • In the past 5 years, Cogent Biosciences' Return on Capital Employed ranged from a high of 0.45% in Q4 2020 and a low of 1.16% during Q1 2018
  • Moreover, its 3-year median value for Return on Capital Employed was 0.78% (2019), whereas its average is 0.78%.
  • Data for Cogent Biosciences' Return on Capital Employed shows a peak YoY increase of 4500bps (in 2019) and a maximum YoY decrease of -6400bps (in 2019) over the last 5 years.
  • Over the past 3 years, Cogent Biosciences' Return on Capital Employed (Quarter) stood at 0.55% in 2018, then tumbled by -45bps to 0.8% in 2019, then skyrocketed by 43bps to 0.45% in 2020.
  • Its last three reported values are 0.45% in Q4 2020, 1.05% for Q3 2020, and 0.87% during Q2 2020.